BORIS in human cancers - A review

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 929-935

  Martin Kleiner, Irena ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

11 Zinc finger protein; BORIS; Cancer; CTCFL; DNA methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BROTHER OF THE REGULATOR OF THE IMPRINTED SITE PROTEIN; CANCER VACCINE; DNA VACCINE; HISTONE DEACETYLASE INHIBITOR; ONCOPROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; BLADDER CANCER; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CARCINOMA CELL; COLON CANCER; COLON CARCINOMA; DEMETHYLATION; DNA BINDING; DNA METHYLATION; EMBRYO DEVELOPMENT; ENDOMETRIUM CANCER; EPIGENETICS; EXPERIMENTAL THERAPY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LEUKEMIA; LEUKEMIA CELL; LUNG CANCER; MELANOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; REVIEW; SPERMATOCYTE; SPERMATOGENESIS; TESTIS CANCER; TUMOR CELL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

ANIMALS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84859102201     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.09.009     Document Type: Article

References (45)

1. D.I. Loukinov, E. Pugacheva, and S. Vatolin BORIS, a novel male-germ-line-specific protein associated with epigenetic reprogammming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma Proc Natl Acad Sci USA 99 10 2002 6806 6811 (Pubitemid 34526213)
2. E.M. Klenova, H.C. Morse III, R. Ohlsson, and V.V. Lobanenkov The novel BORIS+ CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer Semin Cancer Biol 12 5 2002 399 414
3. R. Ohlsson, V. Lobanenkov, and E. Klenova Does CTCF mediate between nuclear organization and gene expression Bioessays 32 1 2010 37 50
4. F. Recillas-Targa, I.A. De La Rosa-Velazquez, E. Soto-Reyes, and L. Benitez-Bribiesca Epigenetic boundaries of tumor suppressor gene promoters: the CTCF connection and its role in carcinogenesis [Review] J Cell Mol Med 10 3 2006 554 568 (Pubitemid 44874270)
5. T.A. Hore, J.E. Deakin, and J.A. Marshall Graves The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes PLoS Genet 4 8 2008 e1000169
6. S. Renaud, E.M. Pugacheva, and D.M. Delgado Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors Nucleic Acids Res 35 21 2007 7372 7388
7. E.M. Pugacheva, T. Suzuki, and S.D. Pack The structural complexity of the human BORIS gene in gametogenesis and cancer PLoS One 5 11 2010 e13872
8. P. Ngyen, G. Bar-Sela, and L. Sun BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression Mol Cell Biol 28 21 2008 6720 6729
9. A.E. Campbell, S.R. Martinez, and J.J.L. Miranda Molecular architecture of CTCFL Biochem Biophys Res Commun 396 3 2010 648 650
10. P. Jelinić, J.-C. Stehle, and P. Shaw The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation PLoS Biol 4 11 2006 1910 1922 (Pubitemid 44760008)
11. M.E. Pembrey Time to take epigenetic inheritance seriously Eur J Hum Genet 10 11 2002 669 671 (Pubitemid 35460572)
12. M.J. Hoffmann, M. Müller, R. Engers, and W.A. Schulz Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies Biochem Pharmacol 72 11 2006 1577 1588 (Pubitemid 44666737)
13. J. Tamminga, P. Kathiria, I. Koturbash, and O. Kovalchuk DNA damage-induced upregulation of miR-709 in the germline downregulates BORIS to counteract abberant DNA hypomethylation Cell Cycle 7 23 2008 3731 3736
14. N. Kouprina, V.N. Noskov, and A. Pavlicek Evolutionary diversification of SPANX-N sperm protein gene structure and expression PLoS One 2 4 2007 e359
15. T. Suzuki, N. Kosaka-Suzuki, and S. Pack Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS Mol Cell Biol 30 10 2010 2473 2484
16. M. Monk, M. Hitchins, and S. Hawes Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development Mol Hum Reprod 14 6 2008 347 355 (Pubitemid 351865908)
17. O. Kholmanskikh, A. Loriot, F. Brasseur, E. De Plaen, and C. De Smet Expression of BORIS in melanoma: lack of association with MAGE-A1 activation Int J Cancer 122 4 2008 777 784
18. Y. Kang, J.A. Hong, G.A. Chen, D.M. Ngyen, and D.S. Schrump Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells Oncogene 26 30 2007 4394 4403 (Pubitemid 47014459)
19. J.I. Risinger, G.V.R. Chandramouli, and G.L. Maxwell Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression Clin Cancer Res 13 6 2007 1713 1719 (Pubitemid 46952936)
20. V. D'Arcy, Z.K. Abduallaev, and N. Pore The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis Clin Cancer Res 12 20 2006 5978 5986 (Pubitemid 44703757)
21. V. D'Arcy, N. Pore, and F. Docquier BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumors Br J Cancer 98 3 2008 571 579 (Pubitemid 351214517)
22. F.F. Costa Epigenomics in cancer management Cancer Manag Res 2 2010 255 265
23. L. Sun, L. Huang, and P. Ngyen DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation Cancer Res 68 8 2008 2726 2735 (Pubitemid 351556270)
24. P. Nguyen, H. Cui, and K.S. Bisht CTCFL/BORIS is a methylation- independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region Cancer Res 68 14 2008 5546 5551
25. S. van de Nobelen, M. Rosa-Garrido, and J. Leers CTCF regulates the local epigenetic state of ribosomal DNA repeats Epigenet Chromatin 3 1 2010 19
26. G.N. Filippova, S. Fagerlie, and E.M. Klenova An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes Mol Cell Biol 16 6 1996 2802 2813 (Pubitemid 26161284)
27. N. Kosaka-Suzuki, T. Suzuki, and E.M. Pugacheva Transcription factor BORIS (brother of the regulator of imprinted sites) directly induces expression of a cancer-testis antigen TSP50, through regulated binding of BORIS to the promoter J Biol Chem 286 31 2011 27378 27388
28. F.P. Fiorentino, M. Macaluso, and F. Miranda CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer Mol Cancer Res 9 2 2011 225 233
29. S. Renaud, D. Loukinov, and L. Alberti BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells Nucleic Acid Res 39 3 2011 862 873
30. I.R. Indran, M.P. Hande, and S. Pervaiz Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase [Review] Mol Aspects Med 31 SI1 2010 21 28
31. C.J. Dougherty, T.E. Ichim, and L. Liu Selective apoptosis of breast cancer cells by siRNA targeting of BORIS Biochem Biophys Res Commun 370 1 2008 109 112
32. A. Woloszynska-Read, S.R. James, and P.A. Link DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer Cancer Immun 7 2007 21 30
33. A. Woloszynska-Read, W. Zhang, and J. Yu Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage Clin Cancer Res 17 8 2011 2170 2180
34. J.A. Hong, Y. Kang, and Z. Abdullaev Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells Cancer Res 65 17 2005 7763 7774 (Pubitemid 41297251)
35. W.C. Hines, A.V. Bazarov, R. Mukhopadhyay, and P. Yaswen BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas PLoS One 5 3 2010 e9738
36. S. Safe, and M. Abdelrahim Sp transcription factor family and its role in cancer Eur J Cancer 41 16 2005 2438 2448 (Pubitemid 41540621)
37. Y. Hosoi, T. Watanabe, and K. Nakagawa Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer Int J Oncol 25 2 2004 461 468
38. I.M. Smith, C.A. Glazer, and S.K. Mithani Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer PLoS One 4 3 2009 e4961
39. C. Cuffel, J.-P. Rivals, and Y. Zaugg Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma Int J Cancer 128 11 2011 2625 2634
40. S. Vatolin, Z. Abdullaev, and S.D. Pack Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes Cancer Res 65 17 2005 7751 7762 (Pubitemid 41297250)
41. S.L. Yoon, D.C. Kim, and S.H. Cho Susceptibility for breast cancer in young patients with short minisatellites alleles of BORIS BMB Rep 43 10 2010 698 703
42. A. Woloszynska-Read, S.R. James, and C. Song BORIS/CTCFL expression is insufficient for cancer-germline antigen expression and DNA hypomethylation in ovarian cell lines Cancer Immun 10 2010 6 14
43. A. Ghochikyan, M. Mkrtichyan, and D. Loukinov Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of the imprinted sites J Immunol 178 1 2007 566 573 (Pubitemid 46039664)
44. D.I. Loukinov, A. Ghochikyan, and M. Mkrtichyan Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant J Cell Biochem 98 5 2006 1037 1043 (Pubitemid 44128346)
45. M. Mkrtichyan, A. Ghochikyan, and H. Davtyan Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma Cell Immunol 270 2 2011 188 197